Puma Biotechnology Inc. buy El_Zocko
Start price
29.12.14
/
50%
€156.43
Target price
08.01.15
€165.00
Performance (%)
5.88%
End price
08.01.15
€165.64
Summary
This prediction ended on 08.01.15 with a price of €165.64. With a performance of 5.88%, the BUY prediction by El_Zocko for Puma Biotechnology Inc. closed with a slight gain. El_Zocko has 50% into this predictionPuma Biotechnology is a publicly traded biopharmaceutical company that develops innovative cancer therapies targeting the most aggressive and difficult-to-treat forms of the disease. Puma's lead product is Nerlynx, an oral medication approved for the treatment of HER2-positive breast cancer, and the company also has a number of other promising drugs in its pipeline. Founded in 2010, Puma is headquartered in Los Angeles, California, and its shares trade on the NASDAQ exchange under the ticker symbol PBYI.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Puma Biotechnology Inc. | 4.966% | 4.966% | 75.018% | 8.036% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by El_Zocko for this prediction
In the thread Puma Biotechnology Inc. diskutieren
PUMA Biotech
ein Reboundkandidat mehr
Stopped prediction by El_Zocko for Puma Biotechnology Inc.
Puma Biotechnology Inc.
Start price
Target price
Perf. (%)
€161.31
25.07.14
25.07.14
€138.00
26.08.14
26.08.14
15.13%
26.08.14
26.08.14
